Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine Enhances IANB Success in Dental Student Third Molar Surgery
TCTR20260110004Completed
- Sponsor
- Faculty of Dentistry, Naresuan University
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of articaine in impacted third molar (I3M) (3 arms), sponsored by Faculty of Dentistry, Naresuan University. Primary endpoint: Profound IANB success rate with articaine. Started Jan 2025; status: completed.
02
Drugs
articaine
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on TCTR20260110004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260110004.